
0:00
NaN:NaN:NaN
A case in which the Court held that generic drug makers cannot be sued for not warning about potentially dangerous side effects on their drug labels, even when they follow federal rules that only require their labels to match those of their brand-name equivalents.
Altri episodi di "U.S. Supreme Court 2010 Term Arguments"



Non perdere nemmeno un episodio di “U.S. Supreme Court 2010 Term Arguments”. Iscriviti all'app gratuita GetPodcast.








